. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Adenocarcinoma/drug therapyAntibodies, Monoclonal/adverse effectsAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedAntineoplastic Combined Chemotherapy Protocols/adverse effectsAntineoplastic Combined Chemotherapy Protocols/standardsAntineoplastic Combined Chemotherapy Protocols/therapeutic useBevacizumabCetuximabColonic Neoplasms/drug therapyDisease ProgressionDisease-Free SurvivalHumansNeoplasm MetastasisRandomized Controlled Trials as TopicRectal Neoplasms/drug therapyTreatment Outcome
Substances: See more » Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedBevacizumabCetuximab
Year: 2006 PMID: 16981668
Source DB: PubMed Journal: Clin Adv Hematol Oncol ISSN: 1543-0790